PROTAC eEF2K Degrader-1 is a proteolysis-targeting chimera (PROTAC) designed to promote targeted degradation of eukaryotic elongation factor 2 kinase (eEF2K/EEF2K), a kinase involved in the regulation of protein translation and cellular stress responses. The compound contains an eEF2K-targeting moiety linked to an E3 ubiquitin ligase-recruiting component through a flexible linker, facilitating formation of a ternary complex and promoting ubiquitination and subsequent degradation of eEF2K through the ubiquitin–proteasome system. The chemical name of PROTAC eEF2K Degrader-1 is 7-amino-3-(2-((2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)ethoxy)ethyl)amino)-2-oxoethyl)-1-ethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxamide.
PROTAC eEF2K Degrader-1 has a CAS No. of 2458170-54-0, a molecular formula of C₃₁H₃₃N₉O₁₁, and a molecular weight of 707.65 g/mol. It is intended for research applications involving eEF2K degradation, targeted protein degradation, PROTAC technology, protein translation, cellular signaling, cancer biology, and tumor research. The compound can be used as a research tool for investigating eEF2K-dependent pathways and the biological effects associated with targeted depletion of eEF2K. For research use only.
关键字： PROTAC;eEF2K degrader;eEF2 kinase;cancer research;
杭州埃米尔生物技术有限公司位于浙江省杭州市钱塘区下沙街道安和药谷，立足杭州生物医药产业集聚区位优势，专注深耕ADC/XDC 生物偶联技术研发服务、医药小分子中间体定制合成两大核心业务，是聚焦抗体偶联药物上下游研发配套的专业化生物技术初创企业，面向药企、CRO 公司、高校科研院所提供从工艺开发、样品合成到质控分析的一站式技术外包解决方案。